REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka Mandragora Nowak sp. j. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Specialty Food Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | All Other Support Services
Full name: Apteka Mandragora Nowak sp. j. Profile Updated: March 18, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Apteka Mandragora Nowak sp. j. is an enterprise in Poland, with the main office in Gryfino. It operates in the Department Stores industry. It was incorporated on December 03, 2012. There was a net sales revenue increase of 18.46% reported in Apteka Mandragora Nowak sp. j.’s latest financial highlights for 2025. Over the same period, its total assets grew by 5.51%. The net profit margin of Apteka Mandragora Nowak sp. j. increased by 4.3% in 2025.

Headquarters
Ul. Zygmunta Krasinskiego 89A
Gryfino; Zachodniopomorskie; Postal Code: 74-101

Contact Details: Purchase the Apteka Mandragora Nowak sp. j. report to view the information.

Basic Information
Financial Auditors:
Purchase the Apteka Mandragora Nowak sp. j. report to view the information.
Incorporation Date:
December 03, 2012
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Apteka Mandragora Nowak sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
18.46%
Total Operating Revenue
19.18%
Operating Profit
4.89%
EBITDA
5.32%
Net Profit/Loss for the Period
4.89%
Total Assets
5.51%
Total Equity
-111.62%
Operating Profit Margin
4.3%
Net Profit Margin
4.3%
Return on Equity (ROE)
-64.62%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?